These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34886965)

  • 41. Left ventricular dysfunction in Duchenne muscular dystrophy.
    James KA; Gralla J; Ridall LA; Do TN; Czaja AS; Mourani PM; Ciafaloni E; Cunniff C; Donnelly J; Oleszek J; Pandya S; Price E; Yang ML; Auerbach SR
    Cardiol Young; 2020 Feb; 30(2):171-176. PubMed ID: 31964455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calcium/Calmodulin Protein Kinase II-Dependent Ryanodine Receptor Phosphorylation Mediates Cardiac Contractile Dysfunction Associated With Sepsis.
    Sepúlveda M; Gonano LA; Viotti M; Morell M; Blanco P; López Alarcón M; Peroba Ramos I; Bastos Carvalho A; Medei E; Vila Petroff M
    Crit Care Med; 2017 Apr; 45(4):e399-e408. PubMed ID: 27648519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Speckle-Tracking Echocardiography in Children With Duchenne Muscular Dystrophy: A Prospective Multicenter Controlled Cross-Sectional Study.
    Amedro P; Vincenti M; De La Villeon G; Lavastre K; Barrea C; Guillaumont S; Bredy C; Gamon L; Meli AC; Cazorla O; Fauconnier J; Meyer P; Rivier F; Adda J; Mura T; Lacampagne A
    J Am Soc Echocardiogr; 2019 Mar; 32(3):412-422. PubMed ID: 30679141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crosstalk between RyR2 oxidation and phosphorylation contributes to cardiac dysfunction in mice with Duchenne muscular dystrophy.
    Wang Q; Wang W; Wang G; Rodney GG; Wehrens XH
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):177-84. PubMed ID: 26555638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanoscale remodeling of ryanodine receptor cluster size underlies cerebral microvascular dysfunction in Duchenne muscular dystrophy.
    Pritchard HAT; Pires PW; Yamasaki E; Thakore P; Earley S
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):E9745-E9752. PubMed ID: 30181262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced binding of calmodulin to the ryanodine receptor corrects contractile dysfunction in failing hearts.
    Hino A; Yano M; Kato T; Fukuda M; Suetomi T; Ono M; Murakami W; Susa T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Koseki N; Kyushiki H; Ikemoto N; Matsuzaki M
    Cardiovasc Res; 2012 Dec; 96(3):433-43. PubMed ID: 22893680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue Doppler imaging detects early asymptomatic myocardial abnormalities in a dog model of Duchenne's cardiomyopathy.
    Chetboul V; Escriou C; Tessier D; Richard V; Pouchelon JL; Thibault H; Lallemand F; Thuillez C; Blot S; Derumeaux G
    Eur Heart J; 2004 Nov; 25(21):1934-9. PubMed ID: 15522473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypersensitivity of excitation-contraction coupling in dystrophic cardiomyocytes.
    Ullrich ND; Fanchaouy M; Gusev K; Shirokova N; Niggli E
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1992-2003. PubMed ID: 19783774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of CaMKII phosphorylation of RyR2 prevents inducible ventricular arrhythmias in mice with Duchenne muscular dystrophy.
    Ather S; Wang W; Wang Q; Li N; Anderson ME; Wehrens XH
    Heart Rhythm; 2013 Apr; 10(4):592-9. PubMed ID: 23246599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ryanodine receptor Ca2+ sensitivity and excitation-contraction coupling in muscular dystrophy and heart failure: similar and yet different.
    Shannon TR
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1965-6. PubMed ID: 19837948
    [No Abstract]   [Full Text] [Related]  

  • 52. Respiratory dysfunction in unsedated dogs with golden retriever muscular dystrophy.
    DeVanna JC; Kornegay JN; Bogan DJ; Bogan JR; Dow JL; Hawkins EC
    Neuromuscul Disord; 2014 Jan; 24(1):63-73. PubMed ID: 24295812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure.
    Yano M; Okuda S; Oda T; Tokuhisa T; Tateishi H; Mochizuki M; Noma T; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ohkusa T; Ikemoto N; Matsuzaki M
    Circulation; 2005 Dec; 112(23):3633-43. PubMed ID: 16330705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne muscular dystrophy.
    Galindo CL; Soslow JH; Brinkmeyer-Langford CL; Gupte M; Smith HM; Sengsayadeth S; Sawyer DB; Benson DW; Kornegay JN; Markham LW
    Pediatr Res; 2016 Apr; 79(4):629-36. PubMed ID: 26672735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs.
    Araujo KP; Bonuccelli G; Duarte CN; Gaiad TP; Moreira DF; Feder D; Belizario JE; Miglino MA; Lisanti MP; Ambrosio CE
    PLoS One; 2013; 8(4):e61367. PubMed ID: 23579193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A computerized MRI biomarker quantification scheme for a canine model of Duchenne muscular dystrophy.
    Wang J; Fan Z; Vandenborne K; Walter G; Shiloh-Malawsky Y; An H; Kornegay JN; Styner MA
    Int J Comput Assist Radiol Surg; 2013 Sep; 8(5):763-74. PubMed ID: 23299128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts.
    Tateishi H; Yano M; Mochizuki M; Suetomi T; Ono M; Xu X; Uchinoumi H; Okuda S; Oda T; Kobayashi S; Yamamoto T; Ikeda Y; Ohkusa T; Ikemoto N; Matsuzaki M
    Cardiovasc Res; 2009 Feb; 81(3):536-45. PubMed ID: 18996969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
    Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for
    Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
    Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of the six-minute walk test to characterize golden retriever muscular dystrophy.
    Acosta AR; Van Wie E; Stoughton WB; Bettis AK; Barnett HH; LaBrie NR; Balog-Alvarez CJ; Nghiem PP; Cummings KJ; Kornegay JN
    Neuromuscul Disord; 2016 Dec; 26(12):865-872. PubMed ID: 27818009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.